Starting on 1 July 2024, the Good Manufacturing Practise (GMP) Standards were implemented in the cosmetics industry, specifically for...

On the 29th of July 2024, the Central Drugs Standard Control Organization (CDSCO) released new circular on the requirement for toxicity...

On the 4th of July 2024, the Department of Health (DH) announced its movement towards the second phase in enhancing the measures of...

After the United Kingdom’s exit from the European Union, the UK and EU established the Windsor Framework, aiming to restore the smooth...

The Therapeutic Goods Administration (TGA) revised the medical device regulations and introduced the amendments on the 26th of June 2024....

On the 2nd of July 2024, the Centre for Medical Device Evaluation (CMDE) announced the clarification by the National Medical Products...

Australia introduces new legislation, The Therapeutic Goods and Other Legislation Amendment (Vaping Reforms) Act 2024, to regulate the...

“NextGen MD Initiative” was introduced by the Health Sciences Authority (HSA) on 13 June 2024 to facilitate the registration of...

The Pharmacy and Poisons Board of Hong Kong (“the Board”) announced that the Refuse-to-File (“RTF”) Mechanism will be enforced in the...

Effective 6 June 2024, the Thailand Food and Drug Administration (TFDA) has executed the new announcement on the registration...

Overall responses from full and thorough jurisdictions based on the current situation in Hong Kong and public consultation led by the...

On the 28th and 30th of May 2024, the Department of Pharmaceuticals of India released 2 Standing Orders regarding the new...

On 3 June 2024, the Therapeutic Goods Administration (TGA) amended its Therapeutic Goods (Manufacturing Principles) Determination...

The Medical Device Authority (MDA) released an announcement on 31 May 2024 about the revocation of the MDA Circular Letter...

Medical devices to be marketed in the European market must obtain CE Marking as proof the devices meet the highest safety, health, and...

Based on the General Directive of the Minister of Health No.1/2024 , announced on 15 April 2024, following the provisions of the Medical...

Effectively from 1 May 2024, the Thai FDA decided to exempt 3 hard copy document submissions for all registrants who deal directly with...

The Central Drugs Standard Control Organization (CDSCO) released a circular on 16 May announcing an extension for the importation of the...

The Indonesia Ministry of Health published an announcement on 11 May 2024, under Announcement No: FR.03.01/E/884/2024 about the...

As part of the initiative to boost foreign investments in the pharmaceutical industry and improve high-quality drug developments and...